Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Epigenetics|October 31, 2013
Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic reviewPauline M W van Kempen, Rob Noorlag, Weibel W Braunius, et al.Oral Oncology|July 10, 2017
Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinomaMarc L Ooft, Jolique A van Ipenburg, Weibel W Braunius, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|September 29, 2006
Grading facial nerve function: why a new grading system, the MoReSS, should be proposedJ Alexander de Ru, Weibel W Braunius, Peter Paul G van Benthem, et al.Head & Neck|January 22, 2019
Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomySandra I Bril, Thomas F Pezier, Bernard M Tijink, et al.Journal of Neurological Surgery. Part A, Central European Neurosurgery|October 5, 2012
Surgical instrument tracking optimizes trans-sphenoidal endoscopic treatment of petrous apex cholesterol granulomaEduard H Voormolen, Sebastien Froelich, Peter A Woerdeman, et al.The Annals of Thoracic Surgery|May 1, 2012
Gastric conduit resection and jejunal interposition for recurrent esophageal cancerPieter C van der Sluis, Roy J J Verhage, Sylvia van der Horst, et al.Biomarkers in Medicine|October 7, 2015
Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysisMarc L Ooft, Weibel W Braunius, Paulien Heus, et al.Head & Neck|November 10, 2021
Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomySandra I Bril, Najiba Chargi, Thomas F Pezier, et al.Cancer Immunology, Immunotherapy : CII|March 20, 2016
Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitorsPauline M W van Kempen, Rob Noorlag, Justin E Swartz, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 14, 2015
TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell CarcinomaPauline M W van Kempen, Froukje J Verdam, Eyleen de Poel, et al.Pageof 3